HCPCS Level IIdrugActive
J7321
Hyalgan supartz visco-3 dose
BETOS: O1E
Effective: 2024-01-01
Referenced in 5 policies
Description
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Visco-3
Manufacturer
Zimmer Biomet
HCPCS Dosage
Per Dose
Billing Units
1.0000
4
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.